Drugs News and Research

RSS

Researchers develop new method for isolating, genome sequencing individual malaria parasite cell

A new method for isolating and genome sequencing an individual malaria parasite cell has been developed by Texas Biomed researchers in San Antonio and their colleagues.

9 May 2014

Study provides potential target for cutting off growth of cancer stem cells

A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells.

9 May 2014

Patients with Parkinson's disease show improvements after exenatide therapy

Follow-Up Study Published in the Journal of Parkinson's Disease Supports an Earlier "Proof of Concept" Trial. A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy.

9 May 2014

Researchers discover new mechanism that distinguishes normal blood stem cells from blood cancers

Researchers at Dartmouth's Norris Cotton Cancer Center have published results from a study Cell Reports that discovers a new mechanism that distinguishes normal blood stem cells from blood cancers.

9 May 2014

Drugmakers realign to reduce costs

Meanwhile, their trade group warns that the patient cost-sharing requirements in some health law plans could restrict prescription drug access.

9 May 2014

Researchers discover new class of drugs to treat nystagmus eye condition

In another example of serendipity advancing scientific research, investigators have discovered a new class of drugs to treat an eye condition called nystagmus.

9 May 2014

Genzyme, Isis receive 2014 Partners in Progress Corporate Award for KYNAMRO injection

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., today announced that they have received the 2014 Partners in Progress Corporate Award from NORD in recognition of KYNAMRO (mipomersen sodium) injection.

9 May 2014

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.

9 May 2014

ImaginAb announces completion of $21M Series B financing

ImaginAb, Inc., a clinical stage biotechnology company that engineers antibodies into smaller protein formats optimized for in vivo molecular imaging, announced today the completion of a $21M Series B financing of the company, led by Mérieux Développement and syndicated with Novartis Venture Funds, Cycad Group and Nextech Invest.

9 May 2014

Sildenafil may help boys suffering from muscular dystrophy disease

Drugs used to treat erectile dysfunction may be able to slow disease progression in boys who suffer from the muscle wasting disease Duchenne muscular dystrophy.

8 May 2014

Antipsychotic medication reduces violent crime rates

People who use antipsychotic medication (such as clozapine or risperidone) to treat psychiatric illness are nearly half as likely to commit a violent crime compared to when they are not using such medication, according to new results published in The Lancet.

8 May 2014

First Edition: May 8, 2014

Today's headlines include reports from a Capitol Hill hearing featuring health insurers' testimony about their experiences with new enrollment under the health law.

8 May 2014

First international molecular screening program at IMPAKT for metastatic breast cancer

While research has made great strides in recent decades to improve and significantly extend the lives of patients with early breast cancer, the needs of patients with advanced or metastatic disease have largely been ignored.

8 May 2014

State highlights: SEIU, hospital strike deal in Calif.; N.Y. Medicaid audit; dental therapists

A selection of health policy stories from California, New York, Connecticut, Georgia, Indiana and North Carolina.

8 May 2014

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Cedars-Sinai Heart Institute researchers have found that a commonly prescribed drug restores blood flow to oxygen-starved muscles of boys with Duchenne muscular dystrophy, a genetic muscle-wasting disease that rarely is seen in girls but affects one in 3,500 male babies, profoundly shortening life expectancy. It is the most common fatal disease that affects children.

8 May 2014

Form of baclofen works better at treating narcolepsy

Neuroscientists at SRI International have found that a form of baclofen, a drug used to treat muscle spasticity, works better at treating narcolepsy than the best drug currently available when tested in mice.

8 May 2014

Psilocybin in magic mushroom inhibits negative emotions in brain, shows study

Emotions like fear, anger, sadness, and joy enable people to adjust to their environment and react flexibly to stress and strain and are vital for cognitive processes, physiological reactions, and social behaviour.

8 May 2014

Researchers create universal flu vaccine

Researchers at the University of Texas Medical Branch are working to create a universal flu vaccine - one that could eliminate the need for an annual flu shot.

8 May 2014

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

A drug typically prescribed for erectile dysfunction or increased pressure in the arteries may help improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to a study published in the May 7, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 May 2014

Bioengineers develop tool that reacts to chemical changes caused by cancer cells

Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.

8 May 2014

Drugs News and Research

Researchers develop new method for isolating, genome sequencing individual malaria parasite cell

Study provides potential target for cutting off growth of cancer stem cells

Patients with Parkinson's disease show improvements after exenatide therapy

Researchers discover new mechanism that distinguishes normal blood stem cells from blood cancers

Drugmakers realign to reduce costs

Researchers discover new class of drugs to treat nystagmus eye condition

Genzyme, Isis receive 2014 Partners in Progress Corporate Award for KYNAMRO injection

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

ImaginAb announces completion of $21M Series B financing

Sildenafil may help boys suffering from muscular dystrophy disease

Antipsychotic medication reduces violent crime rates

First Edition: May 8, 2014

First international molecular screening program at IMPAKT for metastatic breast cancer

State highlights: SEIU, hospital strike deal in Calif.; N.Y. Medicaid audit; dental therapists

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Form of baclofen works better at treating narcolepsy

Psilocybin in magic mushroom inhibits negative emotions in brain, shows study

Researchers create universal flu vaccine

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

Bioengineers develop tool that reacts to chemical changes caused by cancer cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News